ROCKLAGE SCOTT M 4
4 · Aprea Therapeutics, Inc. · Filed May 21, 2020
Insider Transaction Report
Form 4
ROCKLAGE SCOTT M
Director
Transactions
- Sale
Common Stock
2020-05-19$35.15/sh−244,800$8,604,720→ 2,173,748 total(indirect: see footnotes) - Sale
Common Stock
2020-05-19$35.15/sh−10,200$358,530→ 90,572 total(indirect: see footnotes)
Footnotes (3)
- [F1]Shares are held directly by 5AM Ventures IV, L.P.
- [F2]The reporting person is a managing member of 5AM Partners IV, LLC and may be deemed to have shared voting and investment power over the shares beneficially owned by the 5AM Funds. The reporting person disclaims beneficial ownership of the shares of Common Stock and Preferred Stock held directly by the 5AM Funds, except to the extent of his pecuniary interest therein.
- [F3]Shares are held directly by 5AM Co-Investors IV, L.P